What's new

EMEA-003389-PIP01-23

EMEA-003389-PIP01-23

Mar 17, 2025 - 16:38
 0
EMEA-003389-PIP01-23
EMEA-003389-PIP01-23
Read More

Tags:

Previous Article

Curevo rounds up $110M to challenge GSK’s Shringrix, nabs Moncef Slaoui to lead ...

Next Article

The D Brief: Strikes in Yemen; Border destroyer; DOGE vs. nuclear-security agenc...

Related Posts

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Yselty, linzagolix choline, Date of authorisation: 14/06/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0

EMEA-003404-PIP01-23

EMEA-003404-PIP01-23

Feb 17, 2025  0